
Loading, please wait...

Loading, please wait...

Surgeons often face significant challenges when managing aphakia. While several methods exist, iris-claw lens implantation provides a reliable solution for eyes without capsular support. However, traditional enclavation techniques often require significant surgical experience and precision. Recently, experts introduced the Needle Assisted Iris-claw Lens (NAIL) technique to address these common clinical issues.
The NAIL approach utilizes a 10-0 prolene straight needle as an internal pivot. Specifically, this needle acts as a guide during the enclavation process. Consequently, the surgeon can achieve better control and centration of the intraocular lens. In addition, the needle effectively stabilizes the lens during fixation to the iris tissue. Furthermore, clinical data shows promising outcomes with fewer postoperative complications.
For instance, the technique effectively reduces the risk of pupil ovalization. Proper centration remains vital for optimal visual outcomes and patient satisfaction. Overall, NAIL appears to be an efficient and reproducible alternative for most practitioners. Moreover, it significantly lowers the intraoperative difficulty of the procedure compared to manual methods. Clinicians find this approach particularly useful in complex cases requiring high precision.
The NAIL technique uses a 10-0 prolene straight needle as an internal pivot point. This needle guides the enclavation process and ensures the lens remains perfectly centered over the pupil throughout the fixation steps.
Using a needle guide simplifies the enclavation maneuver and increases surgical precision. It specifically reduces intraoperative challenges and helps prevent common complications like pupil distortion or IOL decentration.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or professional services. Always seek the advice of a physician or other qualified health provider regarding any medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Palan P et al. Needle-assisted iris-claw lens implantation: A novel, simplified technique for aphakia without capsular support. Indian J Ophthalmol. 2026 May 01. doi: 10.4103/IJO.IJO_1736_25. PMID: 42060946.
Gonnermann J et al. Retropupillary fixation of an iris-claw intraocular lens in aphakic eyes. J Cataract Refract Surg. 2012;38(12):2095-2101.
Biraghi L. New enclavation technique for iris-claw lens. ESCRS Innovative Category. 2019.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


An overview of the NAIL technique for iris-claw IOL implantation, highlighting its role in simplifying surgery and improving centration for aphakic patients...
5 months ago

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today

Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today

In high-risk pulmonary embolism complicated by severe anemia and active uterine bleeding, systemic thrombolysis is contraindicated. Large-bore aspiration thrombectomy provides rapid hemodynamic rescue without fibrinolysis, supported by inferior vena cava filter placement and multidisciplinary critical care.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today